|Chemical and physical data|
|Molar mass||447.64 g/mol g·mol−1|
|3D model (JSmol)|
NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma. It has reasonable selectivity for the CB2 receptor subtype, having a CB2 affinity of 0.4nM, and 25x selectivity over the related CB1 receptor.
|This cannabinoid related article is a stub. You can help Wikipedia by expanding it.|